Pricing Log in Create free account

Ginkgo Bioworks Holdings, Inc. (DNA) vs Obsidian Therapeutics, Inc (OBX)

Ginkgo Bioworks Holdings, Inc. and Obsidian Therapeutics, Inc are both Biotechnology companies. Obsidian Therapeutics, Inc is the larger, with a market value of $795.6M against $679.1M — 1.2× the size. Across the 5 metrics below, Obsidian Therapeutics, Inc leads on 3 and Ginkgo Bioworks Holdings, Inc. on 2.

Valuation

Metric DNA OBX Biotechnology median
P/E n/m — 11.58
P/S 5.11 n/m 9.61
P/B 1.70 n/m 2.26
Price to free cash flow n/m n/m 26.41
EV/EBITDA n/m n/m 0.72
EV/Sales 3.38 n/m 9.43
Earnings yield (40.24%) — (32.28%)
Free cash flow yield (25.90%) 0.00% (22.27%)

Profitability

Metric DNA OBX Biotechnology median
Gross margin 69.79% — 68.81%
Operating margin (204.50%) — 0.00%
Net margin (191.99%) — 0.00%
Free cash flow margin (132.29%) — 0.00%
Return on equity (52.71%) — (50.30%)
Return on assets (23.53%) — (45.47%)
Return on invested capital (155.79%) 0.00% 0.00%

Growth

Metric DNA OBX Biotechnology median
Revenue growth (TTM) (23.60%) — 6.78%
EPS growth (last fiscal year) 46.49% (11.60%) 29.88%
Revenue growth, 5-year CAGR 17.29% — 9.75%
Net income growth, 5-year CAGR 0.00% — 0.00%

Health

Metric DNA OBX Biotechnology median
Debt to equity 0.00 0.00 0.00
Current ratio 4.72 4.21 4.74
Net debt to EBITDA 1.63 0.77 1.01

Dividend

Metric DNA OBX Biotechnology median
Dividend yield — — 0.39%
Payout ratio — — —

Size

Metric DNA OBX Biotechnology median
Market cap 679.14m 795.63m 168.63m

Compare with another peer

Any metric, up to five companies and an Excel export Powerpack